Delivery Order HHSF223201510027I-HHSF22301002T

Award Date 9/1/17
Potential Completion Date 5/31/22
Potential Value $1.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for a "THIRD PART ASSESSMENT OF COMBINATION PRODUCT REVIEW YEAR" with a potential value of $411,185.02. The contract was issued on June 8, 2018 with a completion date of December 31, 2020, and was not set aside for a specific business type. ERG is an environmental and health consulting firm...
This is a Firm Fixed Price Delivery Order contract awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for $379,580.00. The contract is part of the FDA's "CDER Priority Analysis" program and is focused on the "BENEFIT RISK FRAMEWORK APPLIED TO HUMAN DRUG REVIEW". The contract has an ultimate completion date of September 14, 2017. ERG is an environmental and health consulting firm that provides...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed-price delivery order for $268,832.00 to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The order is for a "Survey of Domestic and Foreign Finished Pharmaceutical Manufacturing Practice, including Supply Chain for Management Practices for Drug Components, Containers, and Closures" and is issued under the existing Economic Studies of FDA Regulations...
This contract was awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for "ECONOMIC STUDIES OF FDA REGULATIONS". The contract is a Delivery Order under the "Economic Studies of FDA Regulations" parent IDIQ contract, with a ceiling value of $333,722.00 and a firm fixed price pricing type. The contract has no set-aside designation and is set to be completed by September 14, 2025. ERG is an...
The Food and Drug Administration (FDA) has awarded a $509,877.20 Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, for the FDA CDER DATA ANALYSIS SEARCH HOST (DASH) project. This contract is part of a larger parent contract called the "Economic Studies of FDA Regulations" Indefinite Delivery/Indefinite Quantity (IDIQ) vehicle. The contract has a period of performance through September 4, 2025 and is a Time and Materials contract...
This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The $99,447.00 contract is for an economic study titled "Recall Cost Case Studies Project" under the FDA's "Economic Studies of FDA Regulations" program. The contract is not set aside. ERG is a known environmental and health consulting firm that provides technical, research, and program management services...
Eastern Research Group Inc. (ERG) was awarded a firm fixed price delivery order against the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) Priority Analysis multiple award indefinite delivery/indefinite quantity (IDIQ) contract. The $873,008 order is for PDUFA VI Assessment of Communication During Drug Development, which will evaluate communication practices between FDA and industry sponsors during the drug development and review process under the...
This is a delivery order under Contract No. 223-03-8500, awarded by the Food and Drug Administration (FDA), a civilian agency, to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The contract has a ceiling value of $79,974.00 and a firm fixed price pricing type. The task order is for drug safety work, with an ultimate completion date of August 12, 2011. ERG is a technical, research, and program management services provider that has expertise in areas such as chemical...
This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation. The $496,714.00 contract is for an "Economics Characterization of Biologics Industry for ORA/OBPO" and is part of the larger "Economic Studies of FDA Regulations" Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. ERG, an environmental and health...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a Firm Fixed Price Delivery Order contract to Eastern Research Group Inc. (ERG), a for-profit Subchapter S Corporation, to update the medical gas industry profile and estimate industry efforts to comply with current federal regulations. The $111,350.00 contract is part of the FDA's broader "Economic Studies of FDA Regulations" program and was not set aside for any socioeconomic business...

The Department of Health and Human Services Food and Drug Administration awarded a Delivery Order contract worth up to $1,153,532.65 to Eastern Research Group, Inc. (ERG), a for-profit environmental and health consulting firm, to provide assessment services for the BSUFA II PROGRAM. The contract is not set aside for any particular business type. The award is associated with the CDER PRIORITY ANALYSIS Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle held by ERG, which provides technical, research, and program management support to the FDA and other federal agencies. Under this and other IDIQ contracts, ERG has performed a range of professional services for government clients.

Generated 3/21/24, 8:54 PM